Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Roswell Park Cancer Institute
PRIMARY OBJECTIVE:
I. Evaluate the feasibility of using the ivWatch device to detect extravasations of peripheral vesicants given in an adult oncology ambulatory population.
SECONDARY OBJECTIVE:
I. Evaluate the clinical outcomes of extravasations that occur with the use of the ivWatch device.
Age
18–95
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients requiring a peripheral IV for infusion of vesicant or vesicant-like agents (chemotherapy, other vesicant medications).
PIV must be inserted
Participant (or legal representative) must understand the nature of this study and verbally consent with the Research Study Information Sheet prior to receiving any study related procedure
You may not be if
Patients who are not getting a vesicant, irritant or vesicant like fluid infused.
Patients who are bruised, scarred, or tattooed in the area of the PIV.
Patients with skin integrity issues at the site of the PIV.
Patients who are on "light precautions."
Not for use in power injectors.
Not for use on mediports, implanted ports, IVAD, central lines, PICC lines.